Product Program year 2025 Source: CMS Open Payments

DXI 9000 Access Immunoassay Analyzer

Device Devices

Open in the dashboard

General payments

$315,744

49 payments

Research payments

$5,219,269

76 payments

Through program year 2025, $315,744 in general payments and $5,219,269 in research payments were reported against DXI 9000 Access Immunoassay Analyzer (Devices).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

8 rows
Year Kind Amount Payments
2025 General $33,479 12
2025 Research $780,986 9
2024 General $275,629 27
2024 Research $133,206 2
2023 General $48 1
2023 Research $38,390 12
2022 General $6,588 9
2022 Research $4,266,686 53

Breakdown

Who paid General payments · program years 2022–2025
  1. Beckman Coulter, Inc. $315,744 49 payments
Top recipients General payments · program year 2025
  1. David Wolk Neurology · Philadelphia, PA $8,180 24% · 2 payments
  2. John-Paul Bettencourt Family Medicine · Fort Myers, FL $7,086 21% · 5 payments
  3. Brandon Allen Emergency Medicine · Gainesville, FL $4,950 15% · 1 payment
  4. James Galvin Behavioral Neurology & Neuropsychiatry · Boca Raton, FL $4,680 14% · 1 payment
  5. Lawrence Honig Neurology · New York, NY $4,680 14% · 1 payment

The top 5 of 7 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Neurology Psychiatry & Neurology $16,500 49% · 3 practitioners
  2. Family Medicine $7,086 21% · 1 practitioner
  3. Emergency Medicine $4,950 15% · 1 practitioner
  4. Behavioral Neurology & Neuropsychiatry Psychiatry & Neurology $4,680 14% · 1 practitioner
  5. Endocrinology, Diabetes & Metabolism Internal Medicine $263 <1% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2025
  1. Florida $16,716 50% · 3 recipients
  2. Pennsylvania $8,443 25% · 2 recipients
  3. New York $4,680 14% · 1 recipient
  4. California $3,640 11% · 1 recipient

Each share is of general payments naming this product in 2025 where a state was reported.

49 general · 76 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record